Jacobs Levy Equity Management Inc. Buys 477,634 Shares of Oscar Health, Inc. (NYSE:OSCR)

Jacobs Levy Equity Management Inc. increased its stake in Oscar Health, Inc. (NYSE:OSCR) by 37.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,741,306 shares of the company’s stock after purchasing an additional 477,634 shares during the period. Jacobs Levy Equity Management Inc. owned approximately 0.70% of Oscar Health worth $23,403,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of OSCR. JPMorgan Chase & Co. grew its position in Oscar Health by 348.7% during the fourth quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company’s stock valued at $139,246,000 after acquiring an additional 8,051,379 shares during the last quarter. BIT Capital GmbH grew its position in Oscar Health by 5,711.6% during the fourth quarter. BIT Capital GmbH now owns 4,473,853 shares of the company’s stock valued at $60,129,000 after acquiring an additional 4,396,872 shares during the last quarter. Deerfield Management Company L.P. Series C grew its position in Oscar Health by 50.7% during the fourth quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company’s stock valued at $159,062,000 after acquiring an additional 3,983,325 shares during the last quarter. Hennessy Advisors Inc. grew its position in Oscar Health by 550.3% during the fourth quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company’s stock valued at $56,292,000 after acquiring an additional 3,544,300 shares during the last quarter. Finally, Gilder Gagnon Howe & Co. LLC grew its position in Oscar Health by 51.4% during the fourth quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company’s stock valued at $85,154,000 after acquiring an additional 2,151,256 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, Wells Fargo & Company cut shares of Oscar Health from an “overweight” rating to an “equal weight” rating and reduced their price target for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Two analysts have rated the stock with a sell rating, two have issued a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $20.08.

Oscar Health Stock Performance

NYSE:OSCR opened at $17.11 on Monday. The firm has a market cap of $4.29 billion, a PE ratio of -855.07 and a beta of 1.75. Oscar Health, Inc. has a fifty-two week low of $11.20 and a fifty-two week high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The business has a 50 day moving average price of $13.34 and a 200-day moving average price of $14.61.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, beating analysts’ consensus estimates of $0.83 by $0.09. The firm had revenue of $3 billion during the quarter, compared to analyst estimates of $2.87 billion. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The business’s quarterly revenue was up 42.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.62 earnings per share. Equities research analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.